Serotonin 5-HT2 Receptor Antagonists
"Serotonin 5-HT2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.
| Descriptor ID |
D058830
|
| MeSH Number(s) |
D27.505.519.625.850.850.200 D27.505.696.577.850.850.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Serotonin 5-HT2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Serotonin 5-HT2 Receptor Antagonists".
This graph shows the total number of publications written about "Serotonin 5-HT2 Receptor Antagonists" by people in this website by year, and whether "Serotonin 5-HT2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin 5-HT2 Receptor Antagonists" by people in Profiles.
-
Inverse agonists of the 5-HT2A receptor reduce nicotine withdrawal signs in rats. Neurosci Lett. 2019 11 20; 713:134524.
-
Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907. Bioorg Med Chem Lett. 2018 05 01; 28(8):1381-1385.
-
Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo. ACS Chem Neurosci. 2018 03 21; 9(3):514-521.
-
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4560-9.
-
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl). 2015 Feb; 232(3):605-21.
-
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci. 2013 Jan 16; 4(1):110-21.
-
Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues. Neuropharmacology. 2011 Sep; 61(3):513-23.
-
Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl). 2005 Mar; 178(2-3):347-50.